These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 2495004

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pharmacological properties of YM-21095, a potent and highly specific renin inhibitor.
    Shibasaki M, Asano M, Fukunaga Y, Usui T, Ichihara M, Murakami Y, Nakano K, Fujikura T.
    Am J Hypertens; 1991 Dec; 4(12 Pt 1):932-8. PubMed ID: 1815649
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. CGP 38 560: orally active, low-molecular-weight renin inhibitor with high potency and specificity.
    Wood JM, Criscione L, de Gasparo M, Bühlmayer P, Rüeger H, Stanton JL, Jupp RA, Kay J.
    J Cardiovasc Pharmacol; 1989 Aug; 14(2):221-6. PubMed ID: 2476594
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pharmacokinetics and cardiovascular effects of YM-21095, a novel renin inhibitor, in dogs and monkeys.
    Shibasaki M, Usui T, Inagaki O, Asano M, Takenaka T.
    J Pharm Pharmacol; 1994 Jan; 46(1):68-72. PubMed ID: 8201530
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Statine-containing dipeptide and tripeptide inhibitors of human renin.
    Kokubu T, Hiwada K, Nagae A, Murakami E, Morisawa Y, Yabe Y, Koike H, Iijima Y.
    Hypertension; 1986 Jun; 8(6 Pt 2):II1-5. PubMed ID: 3087874
    [Abstract] [Full Text] [Related]

  • 16. Effects of SC-56525, a potent, orally active renin inhibitor, in salt-depleted and renal hypertensive dogs.
    McMahon EG, Yang PC, Babler MA, Bittner SE, Suleymanov OD, Cain-Janicki KJ, Bedell LJ, Hanson GJ, Cook CS.
    Hypertension; 1995 Jul; 26(1):95-100. PubMed ID: 7607739
    [Abstract] [Full Text] [Related]

  • 17. Effects of high doses of A-74273, a novel nonpeptidic and orally bioavailable renin inhibitor.
    Verburg KM, Polakowski JS, Kovar PJ, Klinghofer V, Barlow JL, Stein HH, Mantei RA, Fung AK, Boyd SA, Baker WR.
    J Cardiovasc Pharmacol; 1993 Jan; 21(1):149-55. PubMed ID: 7678671
    [Abstract] [Full Text] [Related]

  • 18. KRI-1314: an orally effective inhibitor of human renin.
    Etoh Y, Miyazaki M, Saitoh H, Toda N.
    Jpn J Pharmacol; 1993 Sep; 63(1):109-19. PubMed ID: 8271523
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Comparison of chronic inhibition of renin and converting enzyme in the marmoset.
    Wood JM, Jobber RA, Baum HP, Hofbauer KG.
    Clin Exp Hypertens A; 1987 Sep; 9(2-3):337-43. PubMed ID: 3038392
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.